Anna Kubik is responsible for the process set-up and execution for all regulatory aspects of the company operations. She provides input for study designs, global management of study authorization as well as regulatory documentation development. Mrs. Kubik boasts over 10 years of experience in clinical trials and has extensive knowledge of local regulatory aspects in Europe. Mrs. Kubik holds master’s degree in biology from Jagiellonian University, Poland, and post-graduate degrees in marketing of pharmaceutical product, and methodology of clinical trials.